Tracking the CRDF option chain helps you see every strike and expiry on Cardiff Oncology Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Cardiff Oncology Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CRDF options activity at a glance. Use our scanner to monitor the CRDF option chain in real time and filter for the CRDF options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CRDF stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the CRDF option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where CRDF stock options are being actively traded and where they are not.
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company's TROV-053 is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. The company primarily serves pharmaceutical manufacturers.
The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Cardiff Oncology Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen CRDF options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of CRDF stock options — let the full option chain come to you, pre-filtered and ready to trade.
